Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features

Acta Biomaterialia

Volumn 4, Issue 1, 2008, Pages 192-201

  Lu, Jing ^a   Rao, Masaru P ^b   MacDonald, Noel C ^c   Khang, Dongwoo ^a   Webster, Thomas J ^a  

^a BROWN UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c University of California   (United States)

Author keywords

Endothelial cells; Morphology; Patterning; Stents; Titanium

Indexed keywords

CELL ADHESION; ENDOTHELIAL CELLS; MICROMETERS; TITANIUM;

CELLS ADHESION; CELLS ADHESION AND PROLIFERATIONS; ENDOTHELIAL-CELLS; IN-VITRO; PATTERNING; SURFACE FEATURE; TITANIA; TITANIA SURFACES; VASCULAR ENDOTHELIAL CELLS; VASCULAR STENTS;

STENTS;

NANOMATERIAL; TITANIUM;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CELL ADHESION; CELL DENSITY; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; EQUIPMENT DESIGN; IN VITRO STUDY; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; STENT;

RATTUS;

EID: 36249000630     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2007.07.008     Document Type: Article

References (48)

1. In: Mackay J., and Mensah G. (Eds). The atlas of heart disease and stroke (2004), World Health Organization, Geneva
2. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 9 (2002) 1135-1143
3. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association statistics committee and stroke subcommittee. Circulation 113 6 (2006) E 85-E151
4. Hoffmann R., Mintz G.S., Dussaillant G.R., Popma J.J., Pichard A.D., Satler L.F., et al. Patterns and mechanisms of in-stent restenosis - a serial intravascular ultrasound study. Circulation 94 6 (1996) 1247-1254
5. Farb A., Sangiorgi G., Carter A.J., Walley V.M., Edwards W.D., Schwartz R.S., et al. Pathology of acute and chronic coronary stenting in humans. Circulation 99 1 (1999) 44-52
6. Schwartz R.S., Chronos N.A., and Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 44 7 (2004) 1373-1385
7. Palmaz J.C. New advances in endovascular technology. Texas Heart Inst J 24 3 (1997) 156-159
8. Topol E.J. Coronary-artery stents: gauging, gorging, and gouging [editorial]. N Engl J Med 339 23 (1998) 1702-1704
9. Schömig A., and Kastrati A. Long lesions, long stents and the long process of stent optimization [editorial]. J Am Coll Cardio 34 3 (1999) 660-662
10. Kastrati A., Hall D., and Schömig A. Long-term outcome after coronary stenting [review]. Curr Control Trials Cardiovasc Med 1 1 (2000) 48-54
11. Palmaz J.C., Bailey S., Marton D., and Sprague E. Influence of stent design and material composition on procedural outcome. J Vasc Surg 36 5 (2002) 1031-1039
12. Palmaz J.C. Intravascular stents in the last and the next 10 years. J Endovasc Ther 11 suppl. 2 (2004) 200-206
13. Hara H., Nakamura M., Palmaz J.C., and Schwartz R.S. Role of stent design and coatings on restenosis and thrombosis. Adv Drug Deliver Rev 58 3 (2006) 377-386
14. Whittaker D.R., and Fillinger M.F. The engineering of endovascular stent technology: a review. Vasc Endovasc Surg 40 2 (2006) 85-94
15. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 14 (2003) 1315-1323
16. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary-artery disease. N Engl J Med 350 3 (2004) 221-231
17. McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T.L., Kinnaird T., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 9444 (2004) 1519-1521
18. Virmani R., Guagliumi G., Farb A., Musumeci G., Greico N., Motta T., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation 109 6 (2004) 701-705
19. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladisch E., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 1 (2005) 193-202
20. Ong A.T.L., McFadden E.P., Regar E., de Jaegere P.P.T., van Domburg R.T., and Serruys P.W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 12 (2005) 2088-2092
21. Ong A.T.L., and Serruys P.W. Drug-eluting stents: current issues [key note address]. Texas Heart Inst J 32 3 (2005) 372-377
22. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgio G.M., Stankovic G., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 17 (2005) 2126-2130
23. Nebeker J.R., Virmani R., Bennett C.L., Hoffman J.M., Samore M.H., Alvarez J., et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the research on adverse drug events and reports (RADAR) project. J Am Coll Cardiol 47 1 (2006) 175-181
24. Kuchulakanti P.K., Chu W.W., Torguson R., Ohlmann P., Rha S.W., Clavijo L.C., et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 8 (2006) 1108-1113
25. Spertus J.A., Kettelkamp R., Vance C., Decker C., Jones P.G., Rumsfeld J.S., et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine, therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113 24 (2006) 2803-2809
26. Do drug-eluting stents increase deaths? Retrieved September 11, 2006 from European Society of Cardiology, ESC Event News, 2006 World Congress of Cardiology. .
27. Boston scientific confirms long-term clotting risk of drug-eluting stents. Retrieved September 11, 2006 from Angioplasty.org website. .
28. Shirota T., Yasui H., Shimokawa H., and Matsuda T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 24 13 (2003) 2295-2302
29. Walter D.H., Cejna M., Diaz-Sandoval L., Willis S., Kirkwood L., Stratford P.W., et al. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents. Circulation 110 1 (2004) 36-45
30. Aoki J., Serruys P.W., Van Beusekom H., Ong A.T.L., McFadden E.P., Sianos G., et al. Endothelial progenitor cell capture by stents coated with antibody against CD34 - the HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth - first in man) registry. J Am Coll Cardiol 45 10 (2005) 1574-1579
31. Tanquay J.F. Vascular healing after stenting: the role of 17-beta-estradiol in improving re-endothelialization and reducing restenosis. Can J Cardiol 21 12 (2005) 1025-1030
32. Anis R.R., and Karch K.R. The future of drug eluting stents. Heart 92 5 (2005) 585-588
33. Cho H.J., Kim T.Y., Cho H.J., Park K.W., Zhang S.Y., Kim J.H., et al. The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents. J Am Coll Cardiol 48 2 (2006) 366-374
34. Pelisek J., Fuchs A.T., Kuehnl A., Tian W., Kuhlmann M.T., Choukri M., et al. C-type natriuretic peptide for reduction of restenosis: gene transfer is superior over single peptide administration. J Gene Med 8 7 (2006) 835-844
35. Patel H.J., Su S.-H., Patterson C., and Nguyen K.T. A combined strategy to reduce restenosis for vascular tissue engineering applications. Biotechnol Prog 22 1 (2006) 38-44
36. March K.L., and Trapnell B.C. Pharmacokinetics of local viral vector delivery to vascular tissues: Implications for efficiency and localization of transduction. In: March K L. (Ed). Gene transfer in the cardiovascular system: experimental approaches and therapeutic implications (1997), Kluwer, Dordrecht 483
37. March K.L., Gradus-Pizlo I., Wilensky R.L., Yei S., and Trapnell B.C. Cardiovascular gene therapy using adenoviral vectors: distant transduction following local delivery using a porous balloon catheter. J Am Coll Cardiol 23 1 (1994) 177A
38. Choudhary S., Berhe M., Haberstroh K.M., and Webster T.J. Increased endothelial and vascular smooth muscle cell adhesion on nanostructured Ti and CoCrMo. Int J Nanomed 1 1 (2006) 41-49
39. Parker E.R., Thibeault B.J., Aimi M.F., Rao M.P., and MacDonald N.C. Inductively coupled plasma etching of bulk Ti for MEMS applications. J Electrochem Soc 152 10 (2005) 675-683
40. Webster T.J., and Ejiofor J.U. Increased osteoblast adhesion on nanophase metals: Ti, Ti6Al4V, CoCrMo. Biomaterials 25 19 (2004) 4731-4739
41. Kathuria Y.P. Laser microprocessing of metallic stent for medical therapy. J Mater Process Tech 170 3 (2005) 545-550
42. Takahata K., and Gianchandani Y.B. A planar approach for manufacturing cardiac stents: design, fabrication, and mechanical evaluation. J Microelectromech S 13 6 (2004) 933-939
43. Ingber D.E., Madri J.A., and Folkman J. Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion. In Vitro Cell Dev Biol 23 5 (1987) 387-394
44. Palmaz J.C., Benson A., and Eugene A. Influence of surface topography on endothelialization of intravascular metallic material. J Vasc Interv Radiol 10 4 (1999) 439-444
45. Ben-Ze'ev A. Animal cell shape changes and gene expression. Bioassays 13 5 (1991) 201-212
46. Bettinger C.J., Orrick B., Misra A., Langer R., and Borenstein J.T. Micro fabrication of poly (glycerol-sebacate) for contact guidance applications. Biomaterials 27 12 (2006) 2558-2565
47. Khakbaznejad A., Chehroudi B., and Brunette D.M. Effects of titanium-coated micromachined grooved substrata on orienting layers of osteoblast-like cells and collagen fibers in culture. J Biomed Mater Res 70 2 (2004) 206-218
48. Clark P., Connolly P., Curtis A.S.G., Dow J.A.T., and Wilkinson C.D.W. Cell guidance by ultrafine topography in vitro. J Cell Sci 99 (1991) 73-77